Searchable abstracts of presentations at key conferences in endocrinology

ea0099ep277 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Plasma SHBG levels as an early predictor of response to bariatric surgery

Gabriel-Medina Pablo , Ferrer Roser , Rodriguez-Frias Francisco , Comas Marta , Vilallonga Ramon , Ciudin Andreea , Selva David

Background: Obesity is a growing global health problem and currently bariatric surgery (BS) is the best solution in terms of sustained total weight loss (TWL). However, a significant number of patients present weight regain (WR) in time. There is a lack of biomarkers predicting the response to BS and WR during the follow-up. Plasma SHBG levels, which are low in obesity, increase one month after BS but there is no data of plasma SHBG levels at long term. We performed the presen...

ea0090p276 | Adrenal and Cardiovascular Endocrinology | ECE2023

The impact of Bariatric Surgery on the 1mg Dexamethasone Suppression Test in patients with Severe Obesity

Casteras Anna , Fidilio Enzamaria , Comas Marta , Michael Ortiz Angel , Biagetti Betina , Zabalegui Alba , Filippi Francesca , Giralt Marina , Ferrer Roser , Vilallonga Ramon , Ciudin Andreea

Background: The cortisol suppression test with 1 mg dexamethasone (DST) is a screening test for hypercortisolism with high sensitivity (95%) for serum cortisol cut-off <1.8 μg/dl. However, cortisol tests may give false positive in patients with severe obesity (SO). On the other hand, bariatric surgery (BS) is the most effective treatment for SO, and the operated population is growing. At present there is no reliable data regarding the impact of BS on DST results in pa...